Products for Research Use Only

SARS-CoV-IN-1

CAT: 0804-HY-135855-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-135855-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SARS-CoV-IN-1 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-1 shows anti-Coronavirus activity with an EC50 of 4.9 μM in Vero cells. SARS-CoV-IN-1 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 15.4 and 133.2 nM; and IC90s of 25.7 and 459.1 nM; respectively. Antimalarial and antiviral activities[1].
CAS Number
888958-25-6
UNSPSC
12352005
Target
Parasite; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-in-1.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
ClC1=CC2=C(C=C1)C(NC[C-]34[Fe+2]56789%10%11([C-]%12C8=C9C%10=C%11%12)C3(CNCCO)=C5C6=C47)=CC=N2
Molecular Formula
C23H16ClFeN3O
Molecular Weight
441.69
References & Citations
[1]Biot C, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49 (9) :2845-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Plasmodium